Vol 9, No 3 (2024)
Letter to the Editor
Published online: 2024-08-12
Obesity and out-of-hospital cardiac arrest — a fatal duet
DOI: 10.5603/demj.101763
Disaster Emerg Med J 2024;9(3):136-137.
Abstract
Not available
Keywords: obesitysemaglutidebariatric surgeryreturn of spontaneous circulation (ROSC)
References
- Fehler P, Lewandowski L, Uchmanowicz I, et al. Does obesity influence the return of spontaneous circulation among out-of-hospital cardiac arrest patients? A retrospective cohort study. Disaster and Emergency Medicine Journal. 2024; 9(1): 42–50.
- World Health Organization. Regional Office for Europe. , “WHO European Regional Obesity Report. ; 2022: 2022.
- Kow L, Sharaiha RZ, O'Kane M, et al. Methodology and Results of a Joint IFSO-WGO Delphi Survey of 94 Intercontinental, Interdisciplinary Experts in Obesity Management. Obes Surg. 2023; 33(11): 3337–3352.
- Burki T. European Commission classifies obesity as a chronic disease. Lancet Diabetes Endocrinol. 2021; 9(7): 418.
- Melson E, Ashraf U, Papamargaritis D, et al. What is the pipeline for future medications for obesity? International Journal of Obesity. 2024.
- Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies. Gastroenterology. 2017; 152(7): 1791–1801.
- Müller TD, Clemmensen C, Finan B, et al. Anti-Obesity Therapy: from Rainbow Pills to Polyagonists. Pharmacol Rev. 2018; 70(4): 712–746.
- Müller TD, Blüher M, Tschöp MH, et al. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022; 21(3): 201–223.
- Wilding JPH, Batterham RL, Calanna S, et al. STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021; 384(11): 989–1002.
- Gourcerol G, Melchior C, Wuestenberghs F, et al. Delayed gastric emptying as an independent predictor of mortality in gastroparesis. Aliment Pharmacol Ther. 2022; 55(7): 867–875.